References
- Astrup T. The toxicity of synthetic heparin substitutes. Scandinav. J. Clin. & Lab, Investigation 1953; 5: 137
- Burstein M., Samaille J. Nouvelle methode de séparation et de dosage des lipoprotéins de faible densité. Ann. Biol. Clin 1959; 17: 23
- Carr J. J., Drekter I. J. Simplified rapid technic for the extraction and determination of serum cholesterol without saponification. Clin. Chetn 1956; 2: 353
- Cohn E. J., Strong L. E., Hughes W. L., Jr, Mulford D. J., Ashworth J. N., Melin H., Taylor H. L. Preparation and properties of serum and plasma proteins. J. Am. Chem. Soc 1946; 68: 459
- Donaldson R., Sisson R. B., King E. J., Wotton I.D. P., Macfarlane R. G. Determination of haemoglobin. VII Standardised optical data for absolute estimations. Lancet 1951; 1: 874
- Egeberg O. Personal communication
- Fischer A. Die Bindung von Heparin an Eiweiss. Biochem. Ztschr 1935; 278: 133
- Godal H. C. Precipitation of human fibrinogen with heparin. Scandinav. J. Clin. & Lab. Investigation 1960a; 12: 56
- Godal H. C. Interaction of protamine with human fibrinogen and the significance of this interaction for the coagulation of fibrinogen with thrombin. Ibid 1960b; 12: 433
- Godal H. C. The assay of heparin in thrombin systems. Ibid 1961; 13: 153
- Gormsen J. Koagulationsproblemer ved acut coronarthrombose. Thesis, Copenhagen 1957
- Greenspan E. M. The heparinoid nature of a serum mucoprotein. Science 1951; 114: 395
- Hjort P., Stormorken H. A study of the in vitro and in vivo effect of a synthetic heparinlike anticoagulant: Dextran sulphate. Scandinav. J. Clin. & Lab. Investigation 1957; 9: Suppl. 29
- Holger-Madsen T. The plasma heparin thrombin time. Acta Haemat 1959; 21: 301
- Holger-Madsen T. Heparin resistance in acute coronary occlusion measured by the heparin thrombin time. Ibid 1960; 23: 195
- Holger-Madsen T., Schiøler M. Increased heparin resistance after operations measured by the heparin thrombin time. Acta chir. Scandinav 1960; 118: 257
- Jayle M. F. Evaluation molèculaire de l'haptoglobine par une réaction enzymatique de peroxydation. C. R. Acad. Sci 1940; 211: 574
- Mehl J. W., Humphrey J., Winzler R. J. Mucoproteins of human plasma; electrophoretic studies of mucoproteins from perchloric, acid filtrates of plasma. Proc. Soc. Exper. Biol. & Med 1949; 72: 106
- Nilsson I. M., Yamashina J. Effect of human α,-acid glycoproteins on blood coagulation. Nature 1958; 181: 711
- Nyman M. Serum haptoglobin. Methodological and clinical studies. Scandinav. J. Clin. & Lab. Investigation 1959; 11: Suppl. 39
- Piper J. Toxicology of synthetic polysaccharide polysulphuric acid esters. Acta Pharmacol 1946; 2: 317
- Schmid K. Isolation of a group of α2-glycoproteins from human plasma. J. Am. Chem. Soc 1955; 77: 742
- Smith R. T. A heparin-precipitable fraction of human plasma. II Occurrence and significance of the fraction in normal individuals and in various disease states. J. Clin. Investigation 1957; 36: 605
- Walton K. W. Investigation of the toxicity of series of dextran sulphates of varying molecular weight. Brit. J. Pharmacol 1954; 9: 1
- Weincr M., Jiminez M. Significance of clotting tests augmented by heparin. Am. J. Clin. Path 1956; 26: 243
- Weimer H. E., Mehl J. W., Winzler R. J. Studies on the mucoproteins of human plasma. V. Isolation and characterization of a homogeneous mucoprotein. J. Biol. Chem 1950; 185: 561
- Winzler R. J., Devor A. W., Mehl J. W., Smyth I. M. Studies on the mucoproteins of human plasma. I Determination and isolation. J. Clin. Investigation 1948; 27: 609
- Winzler R. J., Devor A. W., Mehl J. W., Smyth I. M., Smyth I. M. Studies on mucoproteins of human plasma. Plasma mucoprotein levels in cancer patients. Ibid 1948; 27: 617